Lupin, HFCL and RVNL have announced key business wins, while Bosch Global Software Technologies plans an OFS in Bosch Home Comfort India. Apollo Hospi…
1/7Lupin | Lupin has launched Azilsartan Medoxomil tablets in the United States, expanding its portfolio in the cardiovascular segment. The tablet is indicated for the treatment of hypertension in adults, offering another therapeutic option for managing high blood pressure.
2/7HFCL | The company has secured an order worth ₹2,666.09 crore from Rail Vikas Nigam Limited (RVNL) for the BharatNet Phase-III project in Uttar Pradesh.
3/7Bosch Global Software Technologies is set to divest its stake in Bosch Home Comfort India Ltd through an Offer for Sale (OFS), selling up to 7.97% or 21.7 lakh shares. The offer includes a 0.75% green shoe option, with the floor price fixed at ₹1,150 per share, offering a 10% discount to the current market price.
4/7RVNL | RVNL has secured an EPC order worth ₹967.92 crore from East Coast Railway.
5/7RailTel Corporation of India | RailTel received a Letter of Intent (LoI) from the Director IT for a domestic contract to develop disaster recovery IT infrastructure. Valued at ₹52.57 crore (including tax), the order involves supply, installation, integration, and commissioning at a MeitY-empanelled CSP data centre, along with operation and maintenance for five years.
6/7Apollo Hospitals Enterprises | The Reserve Bank of India (RBI) has issued a compounding order in the case of Apollo Hospitals, following which proceedings against the company have been terminated. Apollo Hospitals has paid a compounding amount of ₹17.8 crore to settle the matter.
7/7Balkrishna Industries | The company has appointed Saroj Kumar Khuntia as the Chief Financial Officer of the company, effective June 18, 2026.
